Skip to main content

Machine learning may be a key in helping diagnose Alzheimer's earlier

facebook typing with your brain
Alzheimer’s is a devastating chronic neurodegenerative disease that currently affects about 5.4 million people in the U.S. alone. Alzheimer’s patients suffer progressive mental deterioration, which eventually impairs even basic bodily functions like walking and swallowing.

While Alzheimer’s can increasingly be managed, one of the big challenges of the disease is early diagnosis. MRI machines can be used to confirm advanced cases, but by the time the disease has reached this stage, brain tissue is gone and there is no way to restore it.

Related Videos

Could machine-learning tools be used to help detect and identify Alzheimer’s disease before it is currently possible to do so? That is the mission of researchers from VU University Medical Centre in Amsterdam, led by Dr. Alle Meije Wink.

In a newly published study, Wink and colleagues used machine-learning tools to recognize early patterns in a special type of MRI scan that shows how much blood is reaching different parts of the brain. The researchers analyzed information from 100 patients who likely have Alzheimer’s disease, 60 patients with mild cognitive impairment, 100 with subjective cognitive decline, and a control group of 26 healthy individuals. The machine-learning tool they created was not only able to classify existing patients based on their different levels of cognitive impairment, but was also able to predict Alzheimer’s disease in previously undetected cases.

“We envision our project leading to a tool to assist the neuroradiologist who assesses a scan by providing a predicted patient group label, ideally with a confidence indication, to help and speed up the diagnostic process,” Wink tells Digital Trends. “Furthermore, we think that multimodal data analyses, which integrate imaging data from multiple sources, can improve and enhance the classification by providing higher accuracies and more comprehensive backgrounds about the nature of the diagnosis.”

The end result could be an important advance in not only machine learning, but potentially life-altering research into Alzheimer’s, too.

Editors' Recommendations

Alzheimer’s stole her ability to read. An Alexa-powered chair gave it back
alexa powered magic chair  9

Making of Jacintas Chair 1

If you’ve got a smart speaker like an Amazon Echo or Google Home in your house, there’s a good chance that you’ve come to rely on it in ways that you never expected, whether that’s setting alarms in the kitchen or controlling your smart home gadgets. But it’s probably not been quite such a meaningful innovation for you as the customized Alexa-powered chair built for 69-year-old Alzheimer’s patient Jacinta Dixon.

Read more
The latest weapon in the fight against Alzheimer’s? Flickering lights
Alzheimers research glasses

Alzheimer’s is a lot of things, but it’s most notable for what it’s not. It’s a neurodegenerative disease which affects an estimated 5.5 million people in the United States alone. It’s a debilitating, life-changing disorder that’s intensely cruel in its effects, both to the immediate sufferer and their loved ones. It destroys almost one-third of a brain’s mass, gouging out enormous ravines while piling up heaps of junk amyloid plaques between the neurons. It is not curable.

At least, not yet.

Read more
A brain scan could help reveal if antidepressants will work for a patient
brain wave biometric identification eeg headset

A doctor who is prescribing antidepressants will largely rely on self-reporting on the part of patients to make their decision. Unfortunately, antidepressants don’t work on every patient. That’s bad news -- especially when it comes to treating depressive episodes, which can have a profound impact on people’s lives. Could A.I. and brain-scanning tech help solve the problem?

That’s the ambitious goal of a new piece of research carried out by scientists from Stanford University. Researchers there have been investigating whether EEG brain scans could be used to more accurately predict who is likely to benefit from taking antidepressants.

Read more